Stocks
BioNTech SEBNTX
NASDAQHealthcareBiotechnology$91.19+1.21%
A German biotechnology company focused on developing immunotherapies for cancer and infectious diseases, BioNTech gained prominence through its COVID-19 vaccine partnership with Pfizer. The company's mRNA technology platform and pipeline of oncology candidates make it a key player in the biopharma space. Investors monitor BioNTech for its vaccine revenue streams and clinical trial progress in cancer treatments.
Market Cap: $22.9B52W Range: $79.52 – $124.00
Congressional Interest in BioNTech SE (BNTX)
4 members of Congress have disclosed 13 trades in BioNTech SE (BNTX), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
4
Buys
8
Sells
5
Who in Congress Is Trading BNTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-07 | Valerie Hoyle | sell | $1K – $15K |
| 2024-09-03 | Josh Gottheimer | sell | $1K – $15K |